Tharos Laboratories Makes News with 'Proanthocyanidin Blend'
FOXBORO, Mass., April 20, 2004 -- Tharos Laboratories Inc., (TLI) a maker of pharmaceutical-grade ingredients and retail finished products derived from colorful fruits and plants, will introduce its powerful new antioxidant powder, Procidin(tm), at the upcoming Supply Side East International Trade Show being held at the Baltimore Convention Center May 5-7, 2004 (www.supplysideshow.com).
Antioxidants have been shown to promote cardiovascular, urinary tract, dental, diabetic, immune and gastric health. The Procidin(tm) compound is a physician-formulated blend of proanthocyanidins so unique it is covered by a U.S. Patent. The new Tharos line of Procidin(tm) products includes proanthocyanidin phytochemical compounds recognized for their extraordinary antioxidant properties. Procidin(tm) will be made available as a standardized ingredient to companies who wish to offer unique and effective phytochemical compounds in their finished products.
During the event, the founder and CEO of TLI, Nikos Linardakis, M.D., as well as members of the Board of Directors, will be on hand to answer questions about the new ingredients and meet with executives and buyers from industries such as cosmetics, functional foods, dietary supplements and botanicals.
The Tharos display, "Look for the Butterfly(tm)," will feature the Tharos butterfly logo, representing a union between nature and science. Tharos Laboratories, Inc. will occupy booth No. 1419 and will use this industry event to showcase its new and innovative products.
About the Company / Contact Information
Tharos Laboratories, Inc. is a nutraceutical and pharmaceutical ingredient and retail finished product company focused on extracting naturally occurring phytochemical compounds derived from plant sources. TLI creates high-grade, physician formulated, effective nutritional supplements with clinically recognized health benefits.
Tharos Laboratories is a private company, which anticipates going public in the future; for additional information please contact John Leo. Email: [email protected] Tel: (201)-200-9394